Clinical trial · Interventional
WHITE CAP: Intra-operative Parathyroid Tissue Sensor (PTS)-Guided Assessment of Parathyroid Viability and Surgical Decision-Making
WHITE CAP Trial: Optical Parathyroid Tissue Sensor-Guided Assessment of Parathyroid Viability and Its Impact on Clinical Decision-Making
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Primary hyperparathyroidism is usually cured by removing the single over-active parathyroid adenoma. During surgery, however, surgeons often see a thin rim of normal parathyroid tissue that still "glows" under a near-infrared parathyroid tissue sensor (PTS). It is unclear whether keeping this tissue in place helps preserve hormone function or whether it leaves behind cells that could become over-active again. The WHITE CAP study will compare two common surgical choices: Preservation strategy - the surgeon removes only the adenoma and leaves the glowing rim of normal tissue untouched. En-bloc strategy - the surgeon removes the adenoma together with the glowing rim; if too little parathyroid tissue remains, a small fragment is transplanted into the forearm muscle. About 120 adult patients who have a single parathyroid adenoma will be randomly assigned (like tossing a coin) to one of the two strategies. All operations will use the same FDA-cleared PTS camera that shows the glands in real time without dye or radiation. The main question is whether preserving the normal rim lowers the rate of temporary low blood-calcium (numbness, tingling) during the first two days after surgery. The study will also check long-term results-blood calcium and parathyroid hormone (PTH) levels, symptoms, and any return of the disease-over two years. The PTS imaging itself is painless and adds only a few minutes to the operation. Risks are the same as for standard parathyroid surgery, and participants can withdraw at any time without affecting their usual care.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hyperparathyroidism, Primary | — | UNRESOLVED | — |
| Hypocalcemia | — | UNRESOLVED | — |
| Parathyroid Adenoma | — | UNRESOLVED | — |
| Parathyroid Neoplasms | Parathyroid Gland Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| En-bloc Resection Technique | Procedure | — | UNRESOLVED |
| Near-Infrared Parathyroid Tissue Sensor Imaging (PTS) | Device | — | UNRESOLVED |
| Rim-Preservation Technique | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Arm A - Rim Preservation
- description
- Participants undergo adenoma removal guided by PTS imaging, with deliberate preservation of the NIR-autofluorescent rim of normal parathyroid tissue.
- interventionNames
- Device: Near-Infrared Parathyroid Tissue Sensor Imaging (PTS)
- Procedure: Rim-Preservation Technique
- type
- ACTIVE_COMPARATOR
- label
- Arm B - En-bloc Resection
- description
- Participants undergo PTS-guided en-bloc excision of the adenoma plus its NIR-positive rim; parathyroid autotransplantation performed when indicated.
- interventionNames
- Device: Near-Infrared Parathyroid Tissue Sensor Imaging (PTS)
- Procedure: En-bloc Resection Technique
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Age 18 to 75 years, able to give informed consent. * Biochemically proven primary hyperparathyroidism (elevated serum calcium and inappropriately high PTH). * Pre-operative imaging (sestamibi scan, 4-phase CT, or ultrasound) concordant with a single parathyroid adenoma. * Planned minimally invasive parathyroidectomy using near-infrared parathyroid tissue sensor (PTS) guidance. Exclusion Criteria: * Multiple endocrine neoplasia (MEN 1 or 2) or suspicion of multi-gland disease (\>1 enlarged gland on imaging). * Prior parathyroid or extensive neck surgery causing distorted anatomy. * Need for simultaneous total thyroidectomy or other major neck procedure. * Estimated glomerular filtration rate (eGFR) \< 30 mL/min/1.73 m². * Pregnancy or breastfeeding. * Inability to tolerate general anaesthesia or contraindication to intra-operative PTS imaging.
References
Publications (0)
Data not yet available